3-9744393-GC-GCC
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 9P and 4B. PVS1PP5BS2
The NM_001003694.2(BRPF1):c.2812dup(p.Gln938ProfsTer15) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000011 in 1,457,924 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.000011 ( 0 hom. )
Consequence
BRPF1
NM_001003694.2 frameshift
NM_001003694.2 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.57
Genes affected
BRPF1 (HGNC:14255): (bromodomain and PHD finger containing 1) This gene encodes a bromodomain, PHD finger and chromo/Tudor-related Pro-Trp-Trp-Pro (PWWP) domain containing protein. The encoded protein is a component of the MOZ/MORF histone acetyltransferase complexes which function as a transcriptional regulators. This protein binds to the catalytic MYST domains of the MOZ and MORF proteins and may play a role in stimulating acetyltransferase and transcriptional activity of the complex. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 5 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 3-9744393-G-GC is Pathogenic according to our data. Variant chr3-9744393-G-GC is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 521797.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=1, Uncertain_significance=3, Pathogenic=1}.
BS2
High AC in GnomAdExome4 at 16 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BRPF1 | NM_001003694.2 | c.2812dup | p.Gln938ProfsTer15 | frameshift_variant | 9/14 | ENST00000383829.7 | NP_001003694.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BRPF1 | ENST00000383829.7 | c.2812dup | p.Gln938ProfsTer15 | frameshift_variant | 9/14 | 1 | NM_001003694.2 | ENSP00000373340 | A1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome AF: 0.0000110 AC: 16AN: 1457924Hom.: 0 Cov.: 32 AF XY: 0.00000552 AC XY: 4AN XY: 725222
GnomAD4 exome
AF:
AC:
16
AN:
1457924
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
725222
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:3
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Pathogenic:1Uncertain:1
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2023 | BRPF1: PVS1 - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Aug 18, 2022 | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | May 18, 2017 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mendelics | May 04, 2022 | - - |
Intellectual developmental disorder with dysmorphic facies and ptosis Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Institute for Human Genetics and Genomic Medicine, Uniklinik RWTH Aachen | Feb 09, 2021 | The detected change is reported in the dbSNP database (dbSNP150) with the designation rs762904815. In gnomAD it is listed with a frequency of 0.005% (13/235928) (December 18, 2020). The change has already been entered once as pathogenic in ClinVar (RCV000623556.1). The variant leads to a frameshift. Nonsense and frameshift variants in the BRPF1 gene have already been described as disease causing in the literature (Mattioli et al., 2017; Yan et al., 2017). However, these are not subject to a full nonsense-mediated decay. A loss of function of the mutated allele could be shown in various patients, so that haploinsufficiency is assumed to be the underlying disease mechanism. Based on the current state of knowledge, the effect of the change demonstrated here cannot be predicted with certainty, so that, based on the current state of knowledge, the change can be classified as a "variant of uncertain clinical significance" (ACMG criteria). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at